Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets, CFDs, OTC options or any of our other products work and whether you can afford to take the high risk of losing your money.

69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

  • Updates
  • artificial intelligence
  • autonomous vehicles
  • biotechnology
  • health wellness

5 Top Stories

Altman to Microsoft; AstraZeneca Embraces AI; Weight-loss Buzz

Every day, we handpick the 5 Top Stories stock market investors need to know. In 5 minutes, you’ll learn the stocks, CEOs, and money managers moving markets.

OpenAI: Where Next?

Twitch co-founder Emmett Shear has taken over as CEO of OpenAI following Sam Altman’s ousting. Microsoft [MSFT] announced that Altman is to head its new in-house artificial intelligence (AI) team, where he will be joined by Greg Brockman, OpenAI co-founder. CEO Satya Nadella said Microsoft will “move quickly to provide them with the resources needed for their success”.

AstraZeneca Embraces AI

The pharma giant said on Monday that it has set up a health-tech unit that will apply AI and digital solutions to clinical trials. Called Evinova, it is hoped the unit will significantly reduce the cost and time it takes to bring a drug to market. Two of the world’s leading drug-testers, Parexel and Fortrea [FTRE], have said they will work with the unit. According to AstraZeneca [AZN], the digital health market will top $900bn by 2032.

Weight Loss: the Talk of the Town

Third-quarter (Q3) earnings calls were peppered with references to weight-loss drugs, reflecting the success and popularity of Novo Nordisk’s [NVO] Wegovy and Ozempic, and Eli Lilly’s [LLY] Mounjaro. Reuters analysis of transcripts found terms including “GLP-1” “obesity” and “weight-loss medications” were mentioned 256 times across 29 calls from US and EU healthcare and consumer companies — more than double the 127 mentions in Q2.

Mastercard’s Fraud-Busting AI Partnership

Mastercard [MA] has partnered with Feedzai, a tech platform that uses AI to fight money laundering and financial scams. According to CNBC, Feedzai will integrate with Mastercard’s CipherTrace Armada platform, which helps banks monitor more than 6,000 crypto exchanges for signs of suspicious activity; Feedzai estimates that 40% of scam transactions take place via a crypto exchange.

Cruise CEO Hits the Road

Kyle Vogt, co-founder and CEO of Cruise — the General Motors-owned [GM] self-driving car company — has resigned. This comes just weeks after the firm announced it is halting its driverless operations, and California revoked permits for its vehicles following an accident. Cruise’s board said that it has accepted the resignation and was working to “strengthen public trust”.

Disclaimer Past performance is not a reliable indicator of future results.

CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.

The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.

CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.

*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.

Continue reading for FREE

Latest articles